ABSTRACT
Objective:To evaluate the clinical efficacy and safety of a cream containing madecassoside, 5% panthenolon skin repairing after nonablative fractional 1 565 nm laser therapy.Methods:A total of 84 patients who received nonablative fractional laser surgery in our hospital from April 2017 to April 2018 were included as research objects. The patients were divided into observation group and control group by random number table method, 42 cases in each group. The control group was treated with routine facial intervention after operation, while the observation group was treated with a cream containing madecassoside, 5% panthenolon skin repairing on the basis of routine intervention. The postoperative skin barrier function of the two groups were recorded and compared through skin property system and VISIA complexion analysis system.Results:At 1 and 2 weeks after operation, the sebum content and cuticle water content in the observation group were higher than those in the control group, and the transdermal water loss in the observation group was less than that in the control group, and the differences were statistically significant ( t=4.927, 7.833, 12.430, 4.538, 10.083, 8.017, P<0.05). The erythema index (EI) and melanin index (MI) of the observation group were lower than those of the control group at 1 and 2 weeks after operation, and the incidence of complications was significantly lower than that of the control group ( t=2.392, 2.807, 3.485, 3.009, P<0.05). Conclusions:The application of a cream containing madecassoside, 5% panthenolon in skin repairing is helpful to enhance the moisturizing effect, reduce the complications and promote the early recovery of patients with skin trauma after fractional laser operation.
ABSTRACT
<p><b>BACKGROUND</b>To maximize the preservation of functional pulmonary parenchyma, extend the indication of lung cancer operation and improve the life quality of patients with central lung cancer, reconstruction of carina, bronchoplasty and arterioplasty are widely used with good efficacy. The aim of this study is to summarize the clinical results of reconstruction of carina, bronchoplasty and arterioplasty in the treatment of 79 patients with central lung cancer.</p><p><b>METHODS</b>From June, 1988 to June, 2005, reconstruction of carina, bronchoplasty and arterioplasty were carried out in 79 patients with central lung cancer. The ope- rations included single sleeve lobectomy in 58 cases, double sleeve lobectomy in 15 cases, carinal resection and reconstruction in 6 cases.</p><p><b>RESULTS</b>There was no operative death in this series. Seven patients had operative complications and the operative complication rate was 8.86% (7/79). The 1-, 3-, 5- and 10-year survival rates were 78.5%, 59.5%, 35.4% and 17.7% respectively.</p><p><b>CONCLUSIONS</b>Reconstruction of carina, bronchoplasty and arterioplasty can significantly protect pulmonary function, improve the prognosis and increase the curative rate and long term survival in patients with central lung cancer.</p>
ABSTRACT
Objective To summarize the clinical results of combined procedure of resections and constructions of bronchus,great vessels and heart in the treatment of 79 patients with central lung cancer.Methods From Jun,1988 to Jun,2005,the combined procedure of resections and constructions of bronchus,great vessels and heart were carried out in 74 patients with central lung cancer.The operations included ring of bronchus or sleeve lobectomy in 57 cases,double sleeve lobectomy in 15 cases,carinal resection and reconstruction in 4 cases.Results There was no operative deaths and 7(8.86 %) patients had operative complications.The survival rates of 12,36,60 months and 10 years were 78.5%,59.5%,35.4% and 17.7% respectively.Conclusion With the treatment of sleeve lobectomy or combined with resection and reconstruction of pulmonary artery,great vessels or heart,the pulmonary function can be protected significantly,and the cure rate and the long term survival rate can be improved in patients with central lung cancer.